Meena Bansal, MD
Hepatology · New York, NYNPI 1962432476
Payments from drug & device makers
Across 313 payments — averaging $2772.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Madrigal Pharmaceuticals$277K
- Novo Nordisk$129K
- Intercept Pharmaceuticals, Inc.$128K
- AbbVie$113K
- Siemens Medical Solutions USA, Inc.$84K
- GSK$54K
- plus $82K from 11 others
Across 1 payment — averaging $13,580 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$14K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Madrigal Pharmaceuticals | 62 | $277,096 |
| Novo Nordisk | 57 | $129,309 |
| Intercept Pharmaceuticals, Inc. | 55 | $127,799 |
| AbbVie(2 entities) | 51 | $113,374 |
| Siemens Medical Solutions USA, Inc. | 3 | $84,187 |
| GSK | 20 | $53,697 |
| Boehringer Ingelheim | 27 | $42,218 |
| Intercept Pharma Europe Ltd. | 9 | $28,014 |
| Theratechnologies Inc. | 3 | $5,049 |
| Amarin Pharma, Inc. | 1 | $2,200 |
| Pfizer | 1 | $1,800 |
| Merck | 8 | $1,688 |
| Eli Lilly | 2 | $890 |
| Gilead | 10 | $326 |
| Stryker | 1 | $150 |
| Johnson & Johnson | 2 | $48 |
| Ipsen Biopharmaceuticals, Inc | 1 | $33 |
How this compares
$867,877 in reported general payments places this provider in the 80th percentile of 29 hepatology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hepatology in New York
- Robert BrownNew York$2.1M
- Douglas DieterichNew York$1.1M
- Howard WormanNew York$962K
- Arun JesudianNew York$876K
- Jennifer LeongNew York$379K
- Tatyana KushnerNew York$322K
- Albert MinNew York$284K
- Joseph OdinNew York$115K
- Russell RosenblattNew York$90K
- Thomas SchianoNew York$60K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.